The study to examine the appropriate skin dose in intensity modulated radiotherapy with cetuximab
Phase 1
Completed
- Conditions
- Head and neck cancer
- Registration Number
- JPRN-UMIN000019717
- Lead Sponsor
- ational Cancer Center Hospital, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
Not provided
Exclusion Criteria
Severe coexisting disease Synchronous malignancies Pregnancy, possible pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method